Latest Insider Transactions at Option Care Health, Inc. (OPCH)
This section provides a real-time view of insider transactions for Option Care Health, Inc. (OPCH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Option Care Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Option Care Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2024
|
Michael Bavaro Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,914
+22.4%
|
-
|
|
Feb 20
2024
|
Michael H. Shapiro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94,309
+15.66%
|
-
|
|
Feb 20
2024
|
Christopher L. Grashoff Chief Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,961
+29.64%
|
-
|
|
Feb 20
2024
|
Luke Whitworth Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,603
+15.7%
|
-
|
|
Feb 20
2024
|
Collin Smyser GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
25,542
+26.85%
|
-
|
|
Feb 20
2024
|
John Charles Rademacher Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
249,131
+15.76%
|
-
|
|
Feb 17
2024
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-1.78%
|
$12,672
$33.93 P/Share
|
|
Feb 17
2024
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,183
-0.66%
|
$39,039
$33.93 P/Share
|
|
Feb 17
2024
|
Michael H. Shapiro Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,652
+1.98%
|
-
|
|
Feb 17
2024
|
Christopher L. Grashoff Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
181
-1.09%
|
$5,973
$33.93 P/Share
|
|
Feb 17
2024
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-0.42%
|
$11,946
$33.93 P/Share
|
|
Oct 30
2023
|
Elizabeth D Bierbower Director |
BUY
Open market or private purchase
|
Direct |
3,000
+18.17%
|
$78,000
$26.37 P/Share
|
|
Aug 17
2023
|
R Carter Pate Director |
BUY
Open market or private purchase
|
Direct |
1,465
+1.36%
|
$49,810
$34.32 P/Share
|
|
Aug 14
2023
|
Collin Smyser GC & Corporate Secretary |
BUY
Open market or private purchase
|
Indirect |
2,500
+50.0%
|
$85,000
$34.69 P/Share
|
|
Aug 11
2023
|
Harry M Jansen Kraemer Jr Director |
BUY
Open market or private purchase
|
Direct |
55,000
+19.0%
|
$1,870,000
$34.63 P/Share
|
|
May 19
2023
|
Collin Smyser GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-1.43%
|
$6,664
$28.59 P/Share
|
|
May 19
2023
|
Collin Smyser GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
812
+4.66%
|
-
|
|
May 17
2023
|
Nitin Sahney Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,817
+12.51%
|
-
|
|
May 17
2023
|
Natasha Deckmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,322
+33.6%
|
-
|
|
May 17
2023
|
Elizabeth D Bierbower Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,322
+33.6%
|
-
|
|
May 17
2023
|
John Arlotta Director |
BUY
Grant, award, or other acquisition
|
Indirect |
8,694
+12.32%
|
-
|
|
May 17
2023
|
R Carter Pate Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,117
+8.01%
|
-
|
|
May 17
2023
|
Harry M Jansen Kraemer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,630
+6.57%
|
-
|
|
May 17
2023
|
David W Golding Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,427
+7.71%
|
-
|
|
May 17
2023
|
Timothy P Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,008
+10.05%
|
-
|
|
May 17
2023
|
Elizabeth Quadros Betten Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,185
+10.16%
|
-
|
|
Mar 15
2023
|
Harry M Jansen Kraemer Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,933
+3.99%
|
-
|
|
Mar 10
2023
|
Michael Bavaro Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
6,148
-22.2%
|
$190,588
$31.45 P/Share
|
|
Mar 10
2023
|
Michael Bavaro Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,605
+8.0%
|
$96,705
$21.46 P/Share
|
|
Mar 09
2023
|
Luke Whitworth Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,373
-1.78%
|
$42,563
$31.72 P/Share
|
|
Mar 09
2023
|
Richard Denness Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,522
-1.34%
|
$47,182
$31.72 P/Share
|
|
Mar 01
2023
|
Walgreens Boots Alliance, Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,475,166
-58.96%
|
$464,254,980
$30.3 P/Share
|
|
Feb 23
2023
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
434
-1.84%
|
$13,454
$31.9 P/Share
|
|
Feb 23
2023
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,679
-4.17%
|
$362,049
$31.9 P/Share
|
|
Feb 23
2023
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,421
-1.35%
|
$75,051
$31.9 P/Share
|
|
Feb 23
2023
|
Richard Denness Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,477
-1.29%
|
$45,787
$31.9 P/Share
|
|
Feb 22
2023
|
John Charles Rademacher Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
388,448
+26.22%
|
-
|
|
Feb 22
2023
|
Michael Bavaro Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,863
+26.42%
|
-
|
|
Feb 22
2023
|
Collin Smyser GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
15,811
+42.7%
|
-
|
|
Feb 22
2023
|
Luke Whitworth Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,670
+21.63%
|
-
|
|
Feb 22
2023
|
Michael H. Shapiro Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
158,555
+32.5%
|
-
|
|
Feb 22
2023
|
Richard Denness Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,776
+17.75%
|
-
|
|
Feb 21
2023
|
John Charles Rademacher Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,914
-6.66%
|
$137,592
$28.63 P/Share
|
|
Feb 21
2023
|
John Charles Rademacher Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,087
+13.06%
|
-
|
|
Feb 17
2023
|
Richard Denness Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
760
-1.12%
|
$22,040
$29.38 P/Share
|
|
Feb 17
2023
|
Richard Denness Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,348
+3.35%
|
-
|
|
Feb 17
2023
|
Michael H. Shapiro Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,184
-5.39%
|
$34,336
$29.38 P/Share
|
|
Feb 17
2023
|
Michael H. Shapiro Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,652
+14.25%
|
-
|
|
Feb 17
2023
|
Michael Bavaro Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-3.82%
|
$11,136
$29.38 P/Share
|
|
Oct 03
2022
|
R Carter Pate Director |
SELL
Open market or private sale
|
Direct |
1,928
-1.98%
|
$59,768
$31.97 P/Share
|